Oncopeptides AB (publ) (STO:ONCO)

Oncopeptides AB Revenue

In the year 2024, Oncopeptides AB had annual revenue of 31.65M SEK, down -10.14%. Oncopeptides AB had revenue of 9.91M in the quarter ending December 31, 2024, with 85.76% growth.

• Revenue: 31.65M
• Revenue Growth: -10.14%
• P/S Ratio: 7.57
• Revenue / Employee: 395.60K
• Employees: 80
• Market Cap: 309.87M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	31.65M	-3.57M	-10.14%
Dec 31, 2023	35.22M	26.87M	321.54%
Dec 31, 2022	8.36M	-109.94M	-92.94%
Dec 31, 2021	118.30M	-	-
Dec 31, 2020	-	-	-